Trial finds modest pain-related improvement after virtual training for long COVID care
Patients whose clinicians joined weekly case discussions reported greater improvement in pain interference than control patients over 12 months.
Moderate evidenceHuman studySome caution advised
Medical disclaimer: This article summarizes research findings and is for informational purposes only. It is not medical advice.
Editorial illustration — not from the study.
Researchers assigned 20 primary care clinicians to either an expanded education program or a comparison program. The expanded program included weekly multidisciplinary online case discussions, in addition to monthly webinars and quarterly short courses. The comparison group received the webinars and short courses but not the weekly case discussions.
Among 587 patients whose survey results were analyzed, both groups reported improvements in fatigue, physical function, pain interference, social participation, shortness of breath, and thinking-related function over 12 months. The clearest difference between groups involved pain interference: scores were better in the expanded-program group at 12 months, and more patients in that group had an improvement considered clinically meaningful by the study criteria.
What the study looked at
The researchers examined whether an Extension for Community Healthcare Outcomes, or ECHO, case-based virtual community of practice could improve patient-reported outcomes when used to support primary care clinicians managing long COVID, myalgic encephalomyelitis/chronic fatigue syndrome, and other infection-associated chronic conditions. This was a two-arm, single-blind, cluster randomized controlled trial conducted from December 2021 through October 2023 in an under-resourced Federally Qualified Health Center setting. Twenty clinicians were randomized equally between the two groups. In total, 590 patients were assigned to participating clinicians; survey results from 298 control patients and 289 intervention patients were analyzed at baseline and at 3, 6, 9, and 12 months.
Key findings
Both groups improved over 12 months on several patient-reported measures, including fatigue, physical function, pain interference, social roles, shortness of breath, and applied cognition. At 12 months, the average pain-interference score was 57 in the expanded-program group and 60 in the control group, with a reported P value of 0.009. The statistical analysis estimated a treatment effect on pain interference of -1.95 points, with a 95% confidence interval from -3.79 to -0.10. Also, 43% of patients in the intervention group versus 29% in the control group achieved an improvement of at least 5 points on the study's pain scale. These results show an association between the clinician education model and better pain-interference outcomes in this trial; they do not show that the program caused all of the improvements observed in either group.
Who this may apply to
These findings may be most relevant to patients with long COVID or related infection-associated fatiguing illnesses receiving care from primary care clinicians in settings similar to the participating Federally Qualified Health Center. They should not be assumed to apply to all people with long COVID, to people with different diagnoses, or to other healthcare systems without further research. The study evaluated a clinician education model, not a universally effective approach for individual patients, and the abstract does not establish whether the results would be similar in larger or more diverse populations.
Why it matters
The findings suggest that structured, clinician-focused education may be associated with better pain-related patient-reported outcomes for people with complex, fatiguing illnesses in an under-resourced primary care setting. The study may be relevant to healthcare organizations considering ways to support clinicians who manage conditions with overlapping and changing symptoms. It does not show that the model improves every symptom, nor that it has the same effect in other healthcare systems or patient populations.
Limitations & evidence assessment
Only 20 clinicians took part, and all were from one under-resourced primary care setting, so the results may not represent other clinicians, clinics, or patients. The trial followed patients for 12 months, and the abstract provides limited information about participant characteristics, missing survey data, and how closely clinicians followed the educational program. Outcomes were patient-reported, and both groups improved, with the clearest between-group difference involving pain interference rather than all measured outcomes. Because clinicians, rather than individual patients, were randomized, the small number of clinician groups can make results less precise and may limit confidence in how widely they apply.
Why this evidence level: This was a randomized trial involving human patients, but it included only 20 clinicians in one under-resourced primary care setting. The small number of clinician groups, single setting, and reliance on patient-reported outcomes limit how broadly the findings can be applied.
Evidence levels are editorial estimates derived from study metadata — they are not clinical appraisals.
// Source
Frontiers in Health Services · 2026 · DOI: 10.3389/frhs.2026.1912240
Researchers combined genetic data from more than 1 million human participants to study factors associated with endometriosis. They identified 58 genomic regions, including 27 not previously reported, and used additional molecular analyses to implicate 314 genes. These findings point to possible biological pathways for further research, but they do not establish causes or demonstrate that any treatment will work.
Researchers systematically reviewed laboratory studies of how temperature affects the time it takes arboviruses to become transmissible inside mosquitoes. Across 53 studies covering 17 viruses, higher temperatures were generally linked with greater transmission efficiency and a shorter time to infectiousness for Zika and West Nile viruses, while results for several other viruses were unclear.
This systematic review and meta-analysis examined whether ultra-low-dose computed tomography (CT) can detect pulmonary, or lung, nodules while using less radiation than standard-dose CT. Across 42 studies involving 15,792 patients, pooled sensitivity for nodule detection was 91.9%, but results varied greatly between studies. The review also found that ultra-low-dose CT used an average effective dose of 0.22 millisieverts (mSv), while detection was less reliable for some small or hazy nodules and in patients with a high body mass index.